Table 2 Associations between anti-PC and risk of being a hospitalized obese subject (HO).

From: Antibodies against phosphorylcholine in hospitalized versus non-hospitalized obese subjects

 

Anti-PC IgM

Anti-PC IgG1

Anti-PC IgG2

OR (CI 95%)

p

OR (CI 95%)

P

OR (CI 95%)

p

Unadjusted

Anti-PC

0.53 (0.31–0.90)

0.020

0.60 (0.39–0.93)

0.024

1.01 (0.68–1.51)

0.947

Model 1

Anti-PC

0.54 (0.30–0.99)

0.049

0.58 (0.35–0.95)

0.029

Age

1.22 (1.12–1.34)

1.8 × 10–5

1.23 (1.12–1.35)

1.4 × 10–5

Sex

0.29 (0.11–0.80)

0.017

0.28 (0.10–0.79)

0.016

Model 2

Anti-PC

0.58 (0.30–1.15)

0.120

0.57 (0.33–0.98)

0.044

Age

1.25 (1.13–1.39)

1.9 × 10–5

1.27 (1.14–1.42)

1.8 × 10–5

Sex

1.12 (0.24–5.24)

0.889

1.29 (0.26–6.43)

0.760

Waist circumference

1.09 (1.01–1.18)

0.024

1.10 (1.02–1.19)

0.018

Systolic blood pressure

1.03 (0.99–1.06)

0.158

1.03 (1.00–1.07)

0.083

Fasting blood glucose

1.34 (0.66–2.73)

0.416

1.12 (0.55–2.30)

0.753

Smoking

0.77 (0.21–2.77)

0.685

0.85 (0.23–3.11)

0.804

  1. Values are odds ratios (OR) with 95% confidence intervals (CI 95%).
  2. Anti-PC antibodies against phosphorylcholine, IgM immunoglobulin M, IgG1 immunoglobulin G1, IgG2 immunoglobulin G2.